Key Takeaways
- • Morgan Stanley launched a dedicated private company research product last week, joining JPMorgan Chase and Citigroup in expanding equity research coverage to unlisted firms, signaling a structural shift in how Wall Street monitors competitive threats.
- • The rise of high-impact private companies like OpenAI is forcing traditional equity analysts to extend their research mandate beyond public markets to capture material competitive dynamics affecting their core public stock coverage.
- • Institutional investor demand for private company intelligence is now strong enough to justify dedicated research infrastructure, as asset managers seek to understand how unlisted competitors may disrupt or complement their public equity holdings.
- • This expansion represents a fundamental redrawing of the boundaries between public equity research and private market analysis, driven by the growing financial and strategic clout of private technology firms.
Summary
Wall Street's traditional equity research model is undergoing a significant structural evolution as private companies gain sufficient economic and competitive importance to warrant dedicated analyst coverage. Morgan Stanley's recent launch of a dedicated private company research product marks a notable escalation in this trend, with the firm joining competitors JPMorgan Chase and Citigroup in extending their research capabilities beyond publicly traded securities.
The catalyst for this shift is the emergence of high-impact private companies, particularly in the artificial intelligence sector. OpenAI exemplifies this dynamic—a closely held firm whose technological capabilities and market positioning create material competitive implications for publicly traded technology and software companies that equity analysts cover. Traditional buy-side and sell-side research workflows were designed primarily to analyze financial statements, monitor stock prices, and predict earnings for public companies; they were not structured to systematically track the performance and strategic moves of significant private competitors.
By establishing dedicated private company research products, major Wall Street banks are addressing two critical investor needs simultaneously. First, they enable institutional investors to understand how unlisted competitors may disrupt, complement, or cannibalize the public companies in their portfolios. Second, they capture the relentless institutional appetite for insights into private company performance and strategy—demand that has grown alongside the rise of mega-funding rounds and the extension of private capital markets financing windows.
This expansion reflects a broader recognition among financial institutions that the traditional boundary between public equity research and private market intelligence has become operationally and strategically blurred. For sophisticated institutional investors managing multi-asset portfolios, visibility into both public and private competitive dynamics is increasingly essential to portfolio risk management and alpha generation.
The catalyst for this shift is the emergence of high-impact private companies, particularly in the artificial intelligence sector. OpenAI exemplifies this dynamic—a closely held firm whose technological capabilities and market positioning create material competitive implications for publicly traded technology and software companies that equity analysts cover. Traditional buy-side and sell-side research workflows were designed primarily to analyze financial statements, monitor stock prices, and predict earnings for public companies; they were not structured to systematically track the performance and strategic moves of significant private competitors.
By establishing dedicated private company research products, major Wall Street banks are addressing two critical investor needs simultaneously. First, they enable institutional investors to understand how unlisted competitors may disrupt, complement, or cannibalize the public companies in their portfolios. Second, they capture the relentless institutional appetite for insights into private company performance and strategy—demand that has grown alongside the rise of mega-funding rounds and the extension of private capital markets financing windows.
This expansion reflects a broader recognition among financial institutions that the traditional boundary between public equity research and private market intelligence has become operationally and strategically blurred. For sophisticated institutional investors managing multi-asset portfolios, visibility into both public and private competitive dynamics is increasingly essential to portfolio risk management and alpha generation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.